U.S. Telehealth Market Overview By Fortune Business Insights
Market at a Glance
According to Fortune Business Insights: The U.S. telehealth market was valued at USD 54.00 billion in 2023 and is projected to expand at a compound annual growth rate (CAGR) of 19.6% through 2032. This robust trajectory reflects a fundamental shift in how Americans access and experience healthcare — one that accelerated dramatically during the COVID-19 pandemic and has since become a permanent feature of the national health system.
Get a Sample Research PDF: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/108303
Key Growth Drivers
The market's momentum is fueled by a convergence of demand-side and supply-side factors. On the patient side, growing awareness of virtual care options, coupled with the tangible benefits of convenience, reduced travel, shorter wait times, and lower costs, has driven sustained adoption. On the provider side, approximately 66% of primary care clinicians in southeastern U.S. states reported using telemedicine in their daily practice as of 2022, underscoring how deeply embedded the model has become among healthcare professionals.
Government support has also played a central role. In March 2020, the Centers for Medicare & Medicaid Services (CMS) expanded Medicare coverage for virtual visits, opening the door to millions of patients and significantly broadening the market. Over 150 pieces of legislation have been introduced in the U.S. to improve reimbursement frameworks for telehealth services, reflecting strong bipartisan support for the sector's expansion.
Technological innovation continues to push the market forward as well. Devices such as implantable cardiac monitors now allow physicians to track patients' heart activity remotely in real time, blurring the line between clinical and home-based care. Companies are also launching specialized virtual programs — for example, American Well introduced Musculoskeletal and Dermatology virtual care programs in 2022 — tailoring telehealth solutions to specific chronic and specialty conditions.
Challenges and Restraints
Despite its momentum, the market faces meaningful headwinds. Reimbursement remains a persistent obstacle. Medicare coverage for telehealth services is limited in scope, particularly for patients in non-rural settings or those seeking services outside designated care facilities. With the expiration of pandemic-era emergency flexibilities — the public health emergency ended in May 2023, and extended provisions under the Consolidated Appropriations Act were set to lapse by December 2024 — uncertainty around long-term reimbursement policy has created a more cautious environment for some providers and investors.
Technological barriers also persist, particularly for elderly and underserved populations who may lack reliable internet access or digital literacy. These gaps risk creating a two-tier system where the benefits of telehealth are not equitably distributed.
Market Segmentation
The market is analyzed across four key dimensions: type, application, modality, and end user.
By type, services dominate the market, holding the largest share. This is driven by favorable policy changes, the pandemic-induced surge in service utilization, and a steady stream of new service launches. The products segment, however, is growing rapidly on the back of hardware innovation in remote monitoring and diagnostic devices.
By application, telemedicine is the leading segment, reflecting widespread government promotion and growing public familiarity. Patient monitoring is the fastest-growing application category, driven by healthcare professionals' increasing reliance on remote monitoring devices for chronic disease management.
By modality, the store-and-forward (asynchronous) approach — where patient data is collected and reviewed later — held the largest share in 2022, particularly favored by dermatologists, radiologists, and pathologists. Real-time (synchronous) consultations, however, are growing at the fastest pace, boosted by the pandemic-era normalization of video consultations and their demonstrated ability to manage complex chronic conditions.
By end user, healthcare facilities account for the largest share, supported by institutional adoption and favorable reimbursement. Meanwhile, the homecare segment is expanding rapidly, with home health agencies doubling their use of telehealth solutions since the pandemic began.
Competitive Landscape
The U.S. telehealth market is fragmented, with a growing number of entrants ranging from established healthcare providers to technology-driven start-ups. Teladoc Health Inc. leads the market, benefiting from a large membership base and a high volume of virtual visits. Other significant players include MDLIVE Inc., American Well, Doctor on Demand Inc., CirrusMD, Dictum Health Inc., Grand Rounds Inc., and Included Health Inc.
These companies are competing through product innovation, strategic acquisitions, and platform expansion. American Well's 2021 acquisitions of SilverCloud Health and Conversa Health are illustrative of this trend, adding behavioral health and longitudinal care capabilities to its platform. More recently, Masimo and Temple Health announced a collaboration in March 2023 to advance remote patient monitoring through automation.
Connect with Our Expert for any Queries: https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/108303
Outlook
The U.S. telehealth sector stands at an inflection point. The foundational infrastructure — regulatory frameworks, patient familiarity, provider adoption, and technological capability — is firmly in place. The central challenge ahead is translating pandemic-era momentum into durable, policy-backed growth that extends access to all populations, not just the digitally connected.